Exam 20: Neurodegenerative Diseases, by Jennifer R : Yates, Lander University
Exam 1: Principles of Pharmacology63 Questions
Exam 2: Structure and Function of the Nervous System57 Questions
Exam 3: Chemical Signaling by Neurotransmitters and Hormones54 Questions
Exam 4: Methods of Research in Psychopharmacology67 Questions
Exam 5: Catecholamines60 Questions
Exam 6: Serotonin60 Questions
Exam 7: Acetylcholine56 Questions
Exam 8: Glutamate and Gaba61 Questions
Exam 9: Drug Abuse and Addiction57 Questions
Exam 10: Alcohol58 Questions
Exam 11: The Opioids71 Questions
Exam 12: Psychomotor Stimulants: Cocaine, Amphetamine, and Related Drugs72 Questions
Exam 13: Nicotine and Caffeine63 Questions
Exam 14: Marijuana and the Cannabinoids59 Questions
Exam 15: Hallucinogens, Pcp, and Ketamine58 Questions
Exam 16: Inhalants, Ghb, and Anabolic-Androgenic Steroids57 Questions
Exam 17: Disorders of Anxiety and Impulsivity and the Drugs Used to Treat These Disorders60 Questions
Exam 18: Affective Disorders: Antidepressants and Mood Stabilizers60 Questions
Exam 19: Schizophrenia: Antipsychotic Drugs54 Questions
Exam 20: Neurodegenerative Diseases, by Jennifer R : Yates, Lander University57 Questions
Select questions type
The most significant risk factor for Parkinson's disease is
Free
(Multiple Choice)
4.8/5
(82)
Correct Answer:
D
Which statement about the cholesterol-fed rabbit model of AD is false?
Free
(Multiple Choice)
4.9/5
(81)
Correct Answer:
A
Two of the most frequent symptoms associated with Parkinson's disease include _______ and _______.
Free
(Multiple Choice)
4.7/5
(62)
Correct Answer:
A
The primary cellular abnormalities in AD are _______ and _______. These abnormalities are seen largely in _______ cortex.
(Multiple Choice)
4.7/5
(77)
Which of the following is not a psychiatric symptom seen in AD?
(Multiple Choice)
4.7/5
(64)
Which surprising finding may have efficacy in early detection of PD and thus earlier and more effective treatment?
(Multiple Choice)
4.8/5
(76)
The early symptoms of amyotrophic lateral sclerosis (ALS) result from
(Multiple Choice)
4.9/5
(80)
The likelihood of developing Huntington's disease depends on
(Multiple Choice)
4.8/5
(77)
In AD, Neurodegeneration leads to glutamate release and _______, so _______ can be used in treatment.
(Multiple Choice)
4.7/5
(77)
Treatment with a potassium channel blocker such as Ampyra could improve neurotransmission in demyelinated neurons because it
(Multiple Choice)
4.9/5
(93)
Why might psychiatric disorders such as OCD and bipolar disorder be comorbid with Huntington's disease? Consider the areas of neurodegeneration and the circuits that may be interrupted.
(Essay)
4.8/5
(80)
NMDA receptor agonists and _______ are currently in use for the treatment of AD.
(Multiple Choice)
4.8/5
(91)
The typical pattern of tangles in Alzheimer's disease follows which pattern?
(Multiple Choice)
4.9/5
(85)
In addition to memory problems, a person afflicted with Alzheimer's might exhibit all of the following except for
(Multiple Choice)
4.8/5
(68)
Which of the following is considered a potential risk factor of MS?
(Multiple Choice)
4.8/5
(86)
Delivering drugs to the brain for treatment of AD is difficult because of the blood-brain barrier. Which technology has been used to successfully open the barrier and thus provides hope for future treatment of AD?
(Multiple Choice)
4.9/5
(77)
Describe the stages of pathological changes in Parkinson's disease and explain how a loss of dopaminergic cells in the substantia nigra leads to motor symptoms.
(Essay)
4.8/5
(79)
Name the processes thought to be involved in neuronal degeneration in Parkinson's disease.
(Essay)
4.9/5
(84)
_______ neurons are particularly susceptible to neurofibrillary tangles, which are primarily made of _______ proteins.
(Multiple Choice)
4.7/5
(63)
What is meant by secondary or tertiary symptoms of MS? Include two examples.
(Essay)
4.9/5
(67)
Showing 1 - 20 of 57
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)